Author

Sara Onali

CROHN’S DISEASE PATIENTS WITH USTEKINUMAB-INDUCED REMISSION ARE CHARACTERIZED BY HIGH BASELINE IL23 RECEPTOR EXPRESSION IN THE LAMINA PROPRIA TH1 CELLS
CROHN’S DISEASE PATIENTS WITH USTEKINUMAB-INDUCED REMISSION ARE CHARACTERIZED BY HIGH BASELINE IL23 RECEPTOR EXPRESSION IN THE LAMINA PROPRIA TH1 CELLS

Sara Onali  et al.

DUAL TARGETED THERAPY: A FUTURE STRATEGY FOR THE MANAGEMENT OF REFRACTORY INFLAMMATORY BOWEL DISEASE
DUAL TARGETED THERAPY: A FUTURE STRATEGY FOR THE MANAGEMENT OF REFRACTORY INFLAMMATORY BOWEL DISEASE

Sara Onali  et al.

IRON-DEFICIENCY REFRACTORY ANEMIA (IDRA) IN SARDINIAN INFLAMMATORY BOWEL DISEASE PATIENTS: A LONGITUDINAL OBSERVATIONAL STUDY
IRON-DEFICIENCY REFRACTORY ANEMIA (IDRA) IN SARDINIAN INFLAMMATORY BOWEL DISEASE PATIENTS: A LONGITUDINAL OBSERVATIONAL STUDY

Sara Onali  et al.

Item 1 - 3 / 3
1